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In situ expression of cytokines in IgA nephritis
KAZUO Y0sHI0KA, TSUKASA TAKEMURA, KATSUMI MURAKAMI, MITSURU OKADA,
KAZURO YAGI, HIR0FuMI MIYAzAT0, Kouii MATSUSHIMA, and SUNAO MAKI
Department of Pediatrics, Kinki University School of Medicine, Osaka, and Department of Pharmacology, Cancer Research Institute,
Kanazawa University, Kanazawa, Japan
In situ expression of cytokines in IgA nephritis. We studied mRNA and
protein expression of interleukins (IL) and tumor necrosis factor (TNF)
in renal tissues biopsied from 40 patients with IgA nephritis. Immuno-
fluorescent staining with antibodies to IL-I a, IL-I /3, IL-6, IL-8, TNF-a,
and TNF-/3 was intense in the cytoplasm of cells in glomeruli, which
were dual-stained with an anti-monocyte-macrophage antibody. In
addition, moderate immunofluorescence for TNF-a, and weak staining
for IL-la and IL-6 were occasionally found in resident glomerular cells.
Immunoperoxidase-in situ hybridization dual-labeling revealed that
IL-la, IL-6, and TNF-a mRNA signals were present in intraglomerular
cells reactive with anti-monocyte-macrophage antibody, which further
supported the immunofluorescent findings. Cells expressing IL-ia,
IL-1/3, IL-6, IL-8, TNF-a, and TNF-13 were also observed in the
interstitium. Most of these cells were also labeled with the anti-
monocyte-macrophage antibody. The number of IL-la, IL-6, and
TNF-a-positive cells infiltrating the glomerulus significantly correlated
with mesangial hypercellularity. IL-8 and TNF-a-positive intraglomer-
ular cells were correlated with the magnitude of proteinuria. The
population of interstitial cells positive for IL-la, IL-6, IL-8, and TNF-a
was associated with the grade of tubulointerstitial changes and protein-
uria. There was no correlation between local IL-la, IL-6, and TNF-a
expression in glomeruli or interstitium and serum or urinary levels of
the respective cytokines. These results indicate that several cytokines
were simultaneously expressed by infiltrating monocyte/macrophages
and, to a lesser extent by resident glomerular cells, and that IL-la,
IL-6, and TNF-a may be important as promoters of mesangial prolif-
eration in human IgA nephritis.
Cytokines are polypeptides secreted by specific cells and act
as growth promoters and biological modifiers. Studies using
cultured glomerular cells and animal models of nephritis suggest
that interleukin (IL)-!, IL-6 and tumor necrosis factor (TNF)
are important mediators of injury in glomerulonephritis [1—3].
They are produced by mesangial cells in culture, and have
multiple actions on mesangial cells mediated by an autocrine or
paracrine mechanism [1—3]. IL-i and TNF share the same
biological properties [1, 2, 4—8]; they can induce the formation
of oxygen radicals by cultured mesangial cells, promote tissue
factor expression by endothelial and mesangial cells, stimulate
the synthesis of vasodilating prostagiandin E2, and activate
mesangial cells to generate IL-6 and the neutrophil chemoat-
tractant, IL-8. Furthermore, IL-i stimulates cultured mesangial
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cells to synthesize collagens and basement membrane-degrad-
ing neutral proteinases [1].
IL-i bioactivity or increased expression of IL-i mRNA and
protein has been demonstrated in glomeruli of mice with
autoimmune lupus nephritis [9, 10], rabbits at autologous phase
of antiglomerular basement membrane nephritis [11], rats with
immune complex nephritis [12] and focal glomerulosclerosis
[13], and patients with rapidly progressive crescentic nephritis
[14]. TNF-a immunoreactivity has been detected in the glomer-
uli of mice with lupus nephritis [10], rabbits with anti-glomeru-
lar basement membrane nephritis [15], and rats with acute
aminonucleoside nephrosis [13]. IL-6 is expressed by prolifer-
ating mesangial cells of diseased human giomeruli, and its levels
are elevated in the urine of patients with mesangial proliferative
glomerulonephritis [16].
The role of cytokines in human glomerulonephntis is still
poorly understood. We studied the local expression of cytokine
mRNA and protein in human mesangial proliferative IgA ne-
phritis in an attempt to address the following issues: (I) the
types of cytokines that are expressed in glomeruli and intersti-
tium; (2) the cell source of cytokines; (3) the cytokine of which
the expression is associated with renal tissue injury, particu-
larly mesangial proliferation, and clinical manifestations, in-
cluding proteinuria; and (4) whether or not the presence of
cytokines in serum or urine reflects local production.
Methods
Tissue specimens
Tissue samples consisted of routine renal biopsy specimens
taken from 40 patients (18 males and 22 females, mean age 12
years, between 4 and 21 years old) with primary IgA nephritis.
The diagnosis was made based on clinical, immunofluores-
cence, and light microscopic findings. None had clinical or
biochemical evidence of Henoch-SchOnlein purpura, systemic
lupus erythematosus, or liver disease. At the time of renal
biopsy, all patients had macro- or microscopic hematuria and
proteinuria (0.18 to 3.5 g124 hr). Three patients showed ne-
phrotic syndrome. Creatinine clearance was slightly decreased
in two patients, and was normal in the remainder. None of the
patients were hypertensive. Specific therapy, including admin-
istration of steroids, had not been performed before the time of
biopsy.
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Table 1. Characteristics of antibodies and hybridization probes used
in this study
Specificity Produced by Source
Antibodies
Human IL-la rabbit Genzyme
Human IL-1j3 rabbit Genzyme
Human IL-i receptor mouse Igola Genzyme
Human IL-6 rabbit Genzyme
mouse IgGi, i° Collaborative Bio
Human IL-8 mouse IgGi, sc° K. Matsushima [18]
Human TNF-n rabbit Hayashibara Biochem
mouse IgG I, s° Hayashibara Biochem
Human TNF-/3 rabbit
Oligonucleotide probes"
Hayashibara Biochem
Human IL-la, exons 5, 6 and 7 British Biotech
Human IL-6, exons 2, 3, 4 and 5 British Biotech
Human TNF-a, exons 3, 4A and 4B British Biotech
a Mouse monoclonal antibody
"Probe cocktail containing an equimolar mixture of the exon specific,
single stranded, antisense oligonucleotides
For light microscopic examination, the biopsied tissues were
fixed in 10% buffered formalin and embedded in paraffin. Thin
sections were stained with hematoxylin eosin, periodic acid-
Schiff and methenamine silver. Each biopsy specimen was
assessed with respect to the severity of pathologic features in
the glomeruli, tubules and interstitium. Mesangial hypercellu-
larity, mesangial matrix increase, and tubulointerstitial changes
(tubular atrophy and dilation, cellular infiltration, edema and
fibrosis), were graded semiquantitatively on a 0 to 3 + scale
(absent or minimal, mild, moderate, and marked) according to
methods previously described by Pirani, Salinas-Madrigal and
Koss [17]. The percent of glomeruli involved by crescents or
sclerosis/hyalinosis was determined.
Antibodies and probes
The antibodies used for immunocytochemistry and the oligo-
nucleotide probes for in situ hybridization are listed in Table 1.
Monocyte-macrophages, T and B cells were identified with the
monoclonal antibodies, anti-Leu-M3 (CD14) (mouse IgG, Bec-
ton-Dickinson, Bedford, Massachusetts, USA), T1B (CD5)
(mouse IgG2a, Coulter, Hialeah, Florida, USA), and anti-
Leul2 (mouse IgGl, Becton-Dickinson), respectively. Poly-
morphonuclear cells were detected with fluorescein-isothiocy-
anate (FITC)-labeled rabbit anti-human lactoferrin (Cappel,
Durham, North Carolina, USA). The secondary antibodies,
FITC- or peroxidase-conjugated F(ab')2 goat anti-rabbit IgG
and FITC- or rhodamine-conjugated goat anti-mouse IgO, were
purchased from Cappel.
The absorption test was performed as reported by Fukatsu et
al [19]. The immunofluorescent reactivity of polyclonal and
monoclonal antibodies to IL-6 was abolished by absorption
with recombinant human IL-6 (Genzyme, Cambridge, Massa-
chusetts, USA).
Immunocytochemistry
Indirect immunofluorescent staining was performed as de-
scribed previously [20, 21]. Sections 3 to 4 jim-thick cut from
frozen tissues were incubated with the primary antibody, then
reacted with the appropriate secondary antibody. Cell nuclei
were stained with ethidium bromide. In each section containing
at least three equatorially cut glomeruli, reactive cells and the
total number of glomerulus or interstitial cells (excluding tubu-
lar epithelial cells and arterioles) were counted as previously
described [20, 21]. Dual fluorochrome immunofiuorescence was
performed as follows [20]: monocyte/macrophages, T cells or B
cells were detected with rhodamine-conjugated goat anti-mouse
IgG, and IL-i, IL-6 or TNF were stained with FITC-conjugated
goat anti-rabbit IgO. All secondary antibodies were absorbed
with normal human plasma to avoid background reactivity with
human tissues. After staining, the sections were mounted with
p-phenylenediamine to retard fluorescence fading, then exam-
ined by immunofluorescent or phase contrast-immunofluores-
cent microscopy.
Immunoperoxidase staining was performed as previously
described [20]. In brief, tissues fixed in paraformaldehyde-
lysine-periodate (PLP) were cut into thin sections, then treated
with periodate and sodium borohydroxide to inhibit endoge-
nous peroxide. The sections were incubated with the primary
antibody, followed by the appropriate secondary antibody
preabsorbed with human plasma. The reaction products were
visualized by soaking the slides in diaminobenzidine containing
0.01% hydrogen peroxide. The slides were immersed in PBS to
stop the reaction, washed with PBS three times, dehydrated in
a graded ethanol series, then mounted with a cover-slip. For
immunoelectron microscopic observation, the tissues were
fixed in osmic acid after the PBS wash, then embedded in Epon
812. Ultra-thin sections were cut and viewed under an electron
microscope. Control sections were stained with nonimmune
rabbit or mouse serum or the secondary antibody alone.
In situ hybridization
The hybridization probe for IL-la, IL-6 and TNF-a was a
mixture composed of synthetic, single stranded, antisense
oligonucleotides specific for the exones of each cytokine (Table
1). The probes were labeled with 355-dATP [New England
Nuclear (NEN), Boston, Massachusetts, USA] using terminal
deoxynucleotide transferase (Oligonucleotide 3' end labeling
kit, NEN) to a specific activity of 1 x l0 to io dpmijtg.
In situ hybridization was performed as described elsewhere
[22], with minor modifications. PLP-fixed biopsy tissues, stored
at —70°C until use, were cut into 4 to 6 jim thick sections.
Slide-mounted sections were washed three times with 4 x SSC
(standard saline citrate, 1 x SSC = 0.15 M NaCl in 0.015 M
trisodium citrate) for five minutes, and three times with 1 x
SSC for five minutes, then prehybridized with 1 x Denhardt's
solution (0.02% polyvinyl-pyrrolidone/0.02% bovine serum al-
bumin/0.02% Ficoll 400/4 x SSC, pH 7.0 at room temperature
for one hour. The sections were dehydrated with a graded
ethanol series (50 up to 100%), treated with chloroform, then
immersed in 100% ethanol. The hybridization reaction was
performed at 42°C overnight using 100 pA of hybridization mix
with the 35S-labeled probe at a concentration of about 1 x 106 to
io7 dpm/ml in the hybridization buffer (4 x SSC, 50% deionized
formamide, 1% N-laurolylsarcosine sodium, 0.12 54 phosphate
buffer, pH 7.2, 1 x Denhardt's solution, 2.5% tRNA, 10%
dextran sulfate). After hybridization, sections were rinsed
sequentially in 4 x to 1 )< SSC, then dehydrated with an ethanol
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Table 2. Cytokine expression revealed by immunofluorescence in glomeruli and interstitium of patients with IgA nephritis
Total no.
Glomerulus Interstitium
Per 100
Infiltrating cell Resident cell
of patients
examined Na %
Per
glomerulus" N % Loci° Na %
interstitial
cell"
IL-la 32 19 (59) 0.67 0.81 6 (19) (mes) 24 (75) 0.81 0.70
IL-lp
IL-6
32
32
16 (50)
25 (78)
0.40 0.50
0.76 0.60
0
7 (22) (mes)
14 (44)
21(66)
0.40 0.56
0.75 0.70
IL-8 18 11(61) 0.69 0.76 0 11(61) 0.92 1.1
TNF-a 32 20 (63) 0.68 0.62 22 (69) epi (mes, endo) 16 (50) 0.68 0.05
TNF-/3 32 13 (41) 0.41 0.78 0 17 (53) 0.55 0.72
Abbreviations: mes, mesangium; epi, visceral epithelial cell; endo, endothelial cell.
a Number (percentage) of patients whose tissue has cytokine-positive cells.
b Intraglomerular cytokine-positive infiltrating cells/glomerular cross section are evaluated in each patient, and the mean SD of all patients
evaluated is shown.
Loci in parentheses denote weak immunofluorescence.
d Cytokine-positive cells/l00 interstitial cells are evaluated in each patient, and mean SD of all patients evaluated is shown.
series (60 to 100%). The slides were dipped in emulsion (Ilford's
KS), kept in a light-proof box at 4°C for three to four weeks,
then developed, fixed and counter-stained with hematoxylin-
eosin. The negative controls were hybridization with a syn-
thetic oligonucleotide (RANDOMER, 36 base, NEN) labeled
with 35S-dATP, with the radioactivity adjusted to that of
35S-labeled probes for cytokines, inhibition with an excess of
unlabeled cytokine probes and pretreatment with RNase as
described previously [221.
Immunocytochemistry-in situ hybridization double-labeling
In situ hybridization in combination with immunocytochem-
istry was performed on the same section to simultaneously
detect both proteins and nucleic acids [23]. Sections were first
stained with immunoperoxidase, as outlined above, then in situ
hybridized. The slides were immersed in PBS to stop the color
reaction with diaminobenzidine, then washed in PBS and de-
hydrated in an ethanol series. Air-dried tissues were fixed with
4% formalin and again washed in PBS. The sections were then
processed to the prehybridization step with Denhardt's solu-
tion, following the rest of the in situ hybridization protocol,
described above. The brown diaminobenzidine staining con-
trasted well with the black grains of the positive signals pro-
duced by in situ hybridization.
Serum and urinary IL-i, IL-6 and TNF
Blood was drawn into a sterile tube on the day of renal
biopsy. Serum was rapidly separated after clotting. A 24-hour
urine sample was collected on the day before the renal biopsy,
and cell elements were removed by centrifugation. Test speci-
mens were stored below —20°C until use. IL-la, IL-6 and
TNF-a were assayed in the serum and urine using the following
immunoenzymetric kits: human IL-la EIA kit (Cayman Chem-
ical Co., Ann Arbor, Michigan, USA), human IL-6 ELISA kit
(Toray-Fuji Inc., Tokyo, Japan), and TNF-a-EASIA (Mcd-
genix, Brussels, Belgium). The sensitivity of the assays were 5
pg/mi of IL-la, and 10 pg/ml of IL-6 and TNF-a. The urinary
excretion of these cytokines was expressed as the ratio to
urinary creatinine (nglmg creatinine).
Statistical analysis
The data were analyzed using the Mann-Whitney test, the
Kruskal-Wallis test, and Spearman's rank co-efficients. P <
0.05 was considered to be statistically significant.
Results
Cytokine expression in glomeruli, interstitium, and
blood vessels
Immunohistochemical staining detected cytokine-positive
cells in glomeruli and interstitium of IgA nephritis (Table 2).
Bright, round immunofluorescence with antibodies to IL- 1 a,
IL-l/3, IL-6, IL-8, TNF-a, and TNF-/3 was observed in glomer-
uli (Fig. 1). Immunoperoxidase staining (Fig. 2) and phase-
contrast microscopy (Fig. lE) revealed that this was localized
in the cytoplasm. Dual fluorochrome immunofluorescence re-
vealed that these cells were positive with anti-monocyte-mac-
rophage antibody (Fig. 1 C and D). Immunocytochemistry-in
situ hybridization double-labeling further supported this obser-
vation; IL-l a, IL-6, and TNF-a mRNA signals were detected in
the cells that were positive with immunoperoxidase staining for
monocyte-macrophages (Fig. 3). Immunofluorescence with
weak or moderate intensity was additionally observed in resi-
dent glomerular cells. TNF-a was detected moderately in
visceral epithelial cells, and weakly in endothelial and mesan-
gial cells (Figs. 1 F and 4), whereas IL-la and IL-6 were weak
in mesangial regions. The resident glomerular cells were rarely
labeled with in situ hybridization signals for IL-l a, IL-6, and
TNF-a. Cells immunoreactive with antibodies to IL-la, IL-l/3,
IL-6, IL-8, TNF-a and TNF-/3 infiltrated the interstitium (Fig.
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Fig. 1. Immunofluoresceni staining of cytokines in tissues from patients with IgA nephriiis. A. Intense, round immunofluorescence (arrowhead)
with anti-IL-la antibody in the glomerulus. B. Interstitial cells positive for IL-l/3 (arrowhead). C and D. Dual-staining with polyclonal antibody
to IL-6 (C) and monoclonal antibody to monocyte-macrophages (D) on the same section. Note cytoplasmic staining (arrowhead) for IL-6, and
labeling of the same cell for monocyte-macrophages. E. Cell positive for IL-8 in the glomerulus in a photograph taken between immunofluorescence
and phase-contrast view. F. TNF-a staining. Note intense labeling of a infiltrating cell (arrowhead) and moderate staining in resident glomerular
cells. Small arrows in A, C, and D denote the Bowman's capsule. g: glomerulus. Original magnification: A-F: x 400.
1B). Most of the cells were labeled with anti-monocyte- uli and interstitiurn. The cells were also labeled with anti-
macrophage antibody. monocyte-macrophage antibodies. The glomerular and intersti-
IL-I receptors were identified in cells infiltrating the glomer- tial population of IL-i receptor positive cells correlated with
-
 
r 
-
i 
V
...
,, (I' 
'a
 
•
;. I 
•
 
'a
 
S 
,
 
a
 S.
 a 
Yoshioka et a!: Cytokine expression in IgA nephritis 829
Fig. 2. immunoperoxidase staining for IL-Ia
in IgA nephritis. Positive cells are present in
the glomerulus and interstitium. Original
magnification: x 200.
Fig. 3. IL-Ia mRNA expressing monocyte-macrophages, identtfied by combined in situ hybridization and immunohistochemistry. Peroxidase
staining for monocyte-macrophages (brown staining in the cytoplasm) and hybridization with 35S-labeled oligonucleotide probe encoding IL-la
(dark grains) were sequentially performed using biopsied specimen from a patient with IgA nephritis. Positive cells (arrowheads) are present in the
glomerulus. Original magnification: x 800.
IL-i positive cells in the glomeruli and interstitium, respec- Correlation between cytokine expression and histological and
tively. The IL-i receptor was also weak in the mesangial area, clinical findings
The arterioles were occasionally stained for IL-6 and TNF-a.
The latter was also detected in parietal epithelial cells and The number of IL-ia, IL-6, and TNF-a positive intraglom-
peritubular capillaries in some tissues (Fig. IF). erular cells was significantly correlated with the grade of
4,4 I a
a
4 +
P
it
'—$1
: .3*
.1
.1*
4
-—
be.
-
 
r 
-
i 
V
...
,, (I' 
'a
 
•
;. I 
•
 
'a
 
S 
,
 
a
 S.
 a 
CL
I
4
lv
A
4.,
S
• •
.&' _l-t
830 Yoshioka et at: Cytokine expression in IgA nephritis
Fig. 4. Immunoetectron micrograph of a portion of a glomerutus from a patient with IgA nephritis, stained with antibody to TNF-cr and
peroxidase-labeled secondary antibody. Reaction products are present in the cytoplasm of glomerular epithelial and endothelial cells. Original
magnification: x 8,000. Abbreviations are: CL, capillary lumen; En, endothelial cells; Ep, visceral epithelial cell.
mesangial hypercellularity (Fig. 5). The correlation between
IL-8 and TNF-a positive cells infiltrating the glomerulus and the
magnitude of proteinuria was significant (Fig. 6). The popula-
tion of interstitial cells positive for IL-la, IL-6, IL-8, and
TNF-a was significantly correlated with the histological grading
of tubulo-interstitial changes (Fig. 5) and proteinuria (Fig. 6).
There was no correlation between glomerular or interstitial
expression of any cytokines and the following findings: mesan-
gial matrix increase, percentage of glomerular crescents or
scierosis/hyalinosis, the grade of hematuria, and the time that
elapsed between discovery of the disease and renal biopsy (data
not shown).
Serum and urinary cytokines
Serum and urinary levels of IL-la, IL-6, and TNF-a were
measured in 27 patients with IgA nephritis. Immunoreactive
IL-l a was detected in the urine of 9 (3 3%) patients, and IL-6
was positive in 19(70%). TNF-a was not detected in any of the
urine. The values of IL-I a in patient urine were not significantly
different from that in the urine from 15 healthy control individ-
uals. Urinary IL-6 and TNF-a were undetectable in healthy
controls. There was no significant correlation between serum or
urinary levels of IL-la, IL-6, and TNF-a and the number of
glomerular or interstitial cells positive for the respective cyto-
kines.
Discussion
In this study, we immunocytochemically demonstrated the
concurrent expression of several cytokines in glomeruli and
interstitium of IgA nephritis. IL-l, IL-6, IL-8 and TNF-a were
frequently detected in the glomeruli. The local increase in the
level of IL-l and TNF, which initiates immunologic and inflam-
matory events alone or synergistically, could be associated with
persistent tissue damage. In fact, rabbits infused intravenously
with recombinant TNF developed glomerular endothelial dam-
age and glomerular dysfunction [24], and administration of
antiserum against TNF-a to rats suppressed glomerular injury
in the accelerated autologous form of nephrotoxic serum ne-
phritis [25]. IL-6 is a potential mitogen for mesangial cells. IL-6
transgenic mice exhibited IgO 1 plasmacytosis with prominent
mesangial proliferation [26], but SCID mice that underwent the
same manipulation did not show mesangial alterations, indicat-
ing that IL-6 plus other immunologic factors are necessary for
mesangial proliferation. IL-8 is a chemoattractant for lympho-
cytes as well as neutrophils [27]. IL-8 may play a role in
neutrophils and T cell infiltration, which occurs occasionally,
though not consistently, in IgA nephritis [21, 28, 29]. Immuno-
fluorescence and immunohistochemistry-in situ hybridization
dual staining revealed that IL-l, IL-6, IL-8, and TNF-a were
produced by glomerular monocyte-macrophages, defined as
CDl4 cells. In some tissues, resident glomerular cells also
expressed IL-I, IL-6, and TNF, the amount of which, assessed
by immunofluorescence intensity and in situ hybridization
signal density, was presumed not to be so high as that produced
by monocyte-macrophages. Recent studies using experimental
models, including lupus nephritis [10], antiglomerular basement
membrane nephritis [11, 14], and aminonucleoside nephrosis
[13], have emphasized that macrophages are the major source
of IL-l and TNF production in glomeruli. Expression of IL-l in
the kidney of mice with lupus nephritis is more inclined to IL- 1/3
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Tubulointerstitial changes
Fig. 5. The relationship between cytokine-expressing cells and mor-
phologic changes on renal biopsy. A. The grade of mesangial hypercel-
lularity significantly (P < 0.05, Kruskal-Wallis test) correlated with the
number of IL-la (Li), IL-6 (U), and TNF-a ()-positive cells, but not
with that of IL-8 (0)-positive cells, infiltrating glomeruli. B. The grade
of tubulointerstitial changes significantly (P <0.05, Kruskal-Wallis test)
correlated with the interstitial population of IL-I a (0), IL-6 (U), IL-8
(0), and TNF-a (D)-positive cells. Numbers in parenthesis denote the
number of patients whose tissue was examined.
than IL-la [8, 9], but we detected both IL-la and IL-1/3
proteins, and also IL-la mRNA in our patients.
Our previous studies [21] and those of others [28—30] have
documented monocyte-macrophage infiltration into glomeruli
of IgA nephritis, and its association with pathologic alterations
in glomeruli and the magnitude of proteinuria. The results
presented here add further evidence of the contribution of
monocyte-macrophages to the pathogenesis of human IgA
nephritis. Infiltrating monocytes secrete cytokines that poten-
tially perturb the function of resident mesangial cells. Mesangial
cells, responding to an individual or combination of inflamma-
tory cytokines, produce biological modulators, including other
growth factors (transforming growth factor-/3, platelet derived
growth factor, etc.), eicosanoids, and oxygen radicals [1—3].
Collectively, these processes could lead inflamed glomeruli to
hypercellularity, matrix accumulation, and a reduced filtration
rate. Paracrine growth stimulation by infiltrating monocyte-
macrophages in rats with puromycin aminonucleoside nephro-
sis has been suggested [31].
Mesangial localization of IL-6 in normal glomeruli and its
expansion in the mesangial proliferative glomerulonephritis has
been reported by Fukatsu et al [19]. They also showed a rather
broad expression of immunoreactive IL-6 being localized in
parietal epithelial cells, synechiae, damaged tubular epithelial
cells, and arterial muscle cells, but not in infiltrating leukocytes.
Our results indicate that monocyte-macrophages are a source of
IL-6, and that there is a restricted distribution of IL-6 in
resident cells of diseased kidneys. This discrepancy can be
attributed to the difference in antibody used and tissues exam-
ined, but mostly to the former. The staining pattern they
described was obtained by one particular monoclonal antibody
which was of the 1gM class and unable to neutralize IL-6
activity [32] (A. Fukatsu, personal communication). With the
monoclonal antibody, a reaction with widely shared structures
such as carbohydrate moieties, or an identical but unrelated
epitope might occur. This possibility cannot be excluded even
though the antibody reactivity was completely abolished by
preabsorption with pure antigen. These types of unexpected
cross-reactions of monoclonal antibodies are seldom, but they
do exist [33]. We used one monoclonal and one polyclonal
antibody, obtained from different commercial sources; they
yielded identical results.
The data of Horii et al [16] indicated that the urinary IL-6
level represented both the presence and severity of mesangial
proliferation. In our series, about 70% of the patients had
detectable levels of IL-6 in the urine, but the urinary IL-6/
creatinine ratio did not correlate with the population of glomer-
ular or interstitial cells expressing IL-6. This lack of correlation
may have been because the biopsied tissues we examined did
not reflect the alterations in whole kidneys or that cytokines
synthesized by resident glomerular cells, rather than infiltrating
cells, contributed more to their urinary levels. However, our
immunofluorescent and in situ hybridization data do not sup-
port the latter conjecture. Urinary IL-6 might be, at least in
part, derived from it secreted by tubular cells, or defects in its
catabolism by tubules. IL-i, IL-6, and TNF-a are similar in
molecular mass (ranging 12 to 26 kDa), and are present in
glomeruli and interstitium of IgA nephritis tissues. The former
two were detected in patient urine, but the latter was not.
TNF-a might bind to soluble TNF-a receptors, and hence form
high molecular complexes, which could be retained within the
glomerular capillary barrier, or could be filtered but were
undetectable by the assay. Alternatively, analogous to the
handling of IL-2 [34] or other low molecular weight proteins by
renal tubules, reabsorption or degradation by tubular epithelial
cells under the normal conditions and under those with tubu-
lointerstitial damage might occur. Further information on IL-6
catabolism in the urinary tract system is required before urinary
IL-6 can be used as an indicator of renal pathology.
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Fig. 6. The relationship between the number of cytokine (IL-ia, lL-6, IL-8, and TNF-a)-positive infiltrating cells in the glomeruli (A, B) or
interstitium (C, D) and the magnitude of proteinuria (Spearman's rank coefficients). One dot represents each patient.
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